SCHEMBL3848501

SCHEMBL3848501

Cc1nn(C(c2ccccc2)(c2ccccc2)c2ccccc2)cc1-c1ccc2ncnc(-c3ccc(S(C)(=O)=O)s3)c2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 5/20 0.35
CA1 P00915 5/20 0.35
CA2 P00918 5/20 0.35
CA9 Q16790 5/20 0.35
CD38 P28907 2/20 0.32
CYP1A2 P05177 4/20 0.31
CYP3A4 P08684 4/20 0.31
TSHR P16473 4/20 0.31
CLK4 Q9HAZ1 4/20 0.31
CYP2D6 P10635 3/20 0.31
CYP2C19 P33261 3/20 0.31
MEN1 O00255 2/20 0.31
USP2 O75604 2/20 0.31
LMNA P02545 2/20 0.31
KMT2A Q03164 2/20 0.31
HIF1A Q16665 2/20 0.31
KIT P10721 1/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPK1 P28482 2/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3851993 0.92 CA12 (0.35) CA12CA1CA2CA9CYP1A2
SCHEMBL3846261 0.91 CA12 (0.34) CA12CA1CA2CA9CD38
SCHEMBL3852886 0.89 CYP3A4 (0.33) CA12CA1CA2CA9CD38
SCHEMBL3853047 0.88 CA12 (0.32) CA12CA1CA2CA9CD38
SCHEMBL3856217 0.88 CA12 (0.32) CA12CA1CA2CA9CD38
SCHEMBL3854489 0.88 PTGS2 (0.35) CA12CA1CA2CA9CD38
SCHEMBL3854275 0.88 CYP3A4 (0.33) CA12CA1CA2CA9CD38
SCHEMBL3854329 0.88 CA12 (0.31) CA12CA1CA2CA9
SCHEMBL3848504 0.88 CA12 (0.33) CA12CA1CA2CA9
SCHEMBL3845263 0.87 CYP1A2 (0.34) CA12CA1CA2CA9CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed